These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 3108171

  • 1. Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam.
    Bressa GM, Marini S, Gregori S.
    Int J Clin Pharmacol Res; 1987; 7(2):111-9. PubMed ID: 3108171
    [Abstract] [Full Text] [Related]

  • 2. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam.
    Ceulemans DL, Hoppenbrouwers ML, Gelders YG, Reyntjens AJ.
    Pharmacopsychiatry; 1985 Sep; 18(5):303-5. PubMed ID: 3931107
    [Abstract] [Full Text] [Related]

  • 3. Ritanserin versus lorazepam: a double-blind, cross-over study of reaction times in healthy volunteers.
    Altamura AC, Colacurcio F, Marini S.
    Int J Clin Pharmacol Res; 1989 Sep; 9(3):197-201. PubMed ID: 2568349
    [Abstract] [Full Text] [Related]

  • 4. [Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].
    Botte L, Bienfait J, Dethier J, Even P, Evrard JL, Fraipont J, Goffin L, Willemse P.
    Acta Psychiatr Belg; 1981 Sep; 81(6):595-608. PubMed ID: 6125089
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM, Brion S, Escande M, Ropert R, Sacquepee L, Singer L, Scotto JC.
    Encephale; 1984 Sep; 10(3):135-8. PubMed ID: 6389091
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P, Touchon J, Billardon M.
    Encephale; 1997 Dec; 23(4):290-9. PubMed ID: 9417395
    [Abstract] [Full Text] [Related]

  • 8. Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder.
    Grünberger J, Saletu B, Linzmayer L, Böck G, Weissgram S, Brandstaätter N, Frey R, Saletu-Zyhlarz G.
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):645-54. PubMed ID: 9500129
    [Abstract] [Full Text] [Related]

  • 9. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    Ruiz AT.
    J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
    [Abstract] [Full Text] [Related]

  • 10. Study to establish the indication for the selective S2 antagonist ritanserin.
    Klieser E, Strauss WH.
    Pharmacopsychiatry; 1988 Nov; 21(6):391-3. PubMed ID: 3149751
    [Abstract] [Full Text] [Related]

  • 11. [Modification of cognitive functions by 2 anxiolytic treatments in patients suffering from generalized anxiety].
    Samuelian JC, Billardon M, Guillou N.
    Encephale; 1995 Nov; 21(2):147-53. PubMed ID: 7781586
    [Abstract] [Full Text] [Related]

  • 12. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study].
    Bernardi F, Fossi L, Faravelli C, Corsini GU, Varricchio MC.
    Riv Patol Nerv Ment; 1984 Nov; 105(1):1-13. PubMed ID: 6571441
    [Abstract] [Full Text] [Related]

  • 13. 5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin.
    Bersani G, Pozzi F, Marini S, Grispini A, Pasini A, Ciani N.
    Acta Psychiatr Scand; 1991 Apr; 83(4):244-8. PubMed ID: 1903019
    [Abstract] [Full Text] [Related]

  • 14. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
    Zung WW, Daniel JT, King RE, Moore DT.
    J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
    [Abstract] [Full Text] [Related]

  • 15. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR, Sramek JJ, Wardle TS, Hesselink JM, Roeschen JK.
    Psychopharmacol Bull; 1993 Jul; 29(2):303-8. PubMed ID: 7904761
    [Abstract] [Full Text] [Related]

  • 16. Serotonin antagonism in panic disorder: an open trial with ritanserin.
    Griez E, Pols H, Lousberg H.
    Acta Psychiatr Belg; 1988 Jul; 88(5-6):372-7. PubMed ID: 3152708
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A, Jiménez-Ferrer E, Zamilpa A, Morales-Valdéz M, García-Valencia CE, Tortoriello J.
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [Abstract] [Full Text] [Related]

  • 18. Effects of ritanserin on sleep disturbances of dysthymic patients.
    Paiva T, Arriaga F, Wauquier A, Lara E, Largo R, Leitao JN.
    Psychopharmacology (Berl); 1988 Jul; 96(3):395-9. PubMed ID: 3146774
    [Abstract] [Full Text] [Related]

  • 19. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A.
    Rev Neurol (Paris); 1994 Jul; 150(1):3-15. PubMed ID: 7801037
    [Abstract] [Full Text] [Related]

  • 20. Pilot study of a specific serotonergic antagonist, pirenperone, in the treatment of anxiety disorders.
    Ansseau M, Doumont A, Thiry D, Gelders Y.
    Acta Psychiatr Belg; 1983 Jul; 83(5):517-24. PubMed ID: 6670580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.